Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 16124999)

1.

Chemokine receptor CXCR3: an unexpected enigma.

Liu L, Callahan MK, Huang D, Ransohoff RM.

Curr Top Dev Biol. 2005;68:149-81. Review.

PMID:
16124999
2.

Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.

McColl SR, Mahalingam S, Staykova M, Tylaska LA, Fisher KE, Strick CA, Gladue RP, Neote KS, Willenborg DO.

Lab Invest. 2004 Nov;84(11):1418-29.

3.

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM.

J Immunol. 2006 Apr 1;176(7):4399-409.

4.

Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.

Hildebrandt GC, Corrion LA, Olkiewicz KM, Lu B, Lowler K, Duffner UA, Moore BB, Kuziel WA, Liu C, Cooke KR.

J Immunol. 2004 Aug 1;173(3):2050-9.

5.

Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis.

Kohler RE, Comerford I, Townley S, Haylock-Jacobs S, Clark-Lewis I, McColl SR.

Brain Pathol. 2008 Oct;18(4):504-16. doi: 10.1111/j.1750-3639.2008.00154.x. Epub 2008 Apr 11.

PMID:
18422759
6.

CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.

Müller M, Carter SL, Hofer MJ, Manders P, Getts DR, Getts MT, Dreykluft A, Lu B, Gerard C, King NJ, Campbell IL.

J Immunol. 2007 Sep 1;179(5):2774-86.

7.

Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation.

Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, Peterson LB, Wicker LS, DeMartino JA.

J Leukoc Biol. 2003 Jun;73(6):771-80.

8.

Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.

Narumi S, Kaburaki T, Yoneyama H, Iwamura H, Kobayashi Y, Matsushima K.

Eur J Immunol. 2002 Jun;32(6):1784-91.

PMID:
12115662
10.
11.

T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.

Kivisäkk P, Trebst C, Liu Z, Tucky BH, Sørensen TL, Rudick RA, Mack M, Ransohoff RM.

Clin Exp Immunol. 2002 Sep;129(3):510-8.

12.

Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice.

Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, Zahner G, Heymann F, Kurts C, Hopfer H, Helmchen U, Haag F, Schneider A, Stahl RA.

J Am Soc Nephrol. 2007 Jul;18(7):2071-84. Epub 2007 May 30.

13.
14.

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.

Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM.

Cancer Res. 2004 Jun 1;64(11):4010-7.

16.

Targeting monocyte recruitment in CNS autoimmune disease.

Izikson L, Klein RS, Luster AD, Weiner HL.

Clin Immunol. 2002 May;103(2):125-31. Review.

PMID:
12027417
17.

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4814-9. doi: 10.1073/pnas.0801544105. Epub 2008 Mar 17.

18.

CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function.

Medoff BD, Wain JC, Seung E, Jackobek R, Means TK, Ginns LC, Farber JM, Luster AD.

J Immunol. 2006 Jun 1;176(11):7087-95.

19.

Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.

Colvin RA, Campanella GS, Sun J, Luster AD.

J Biol Chem. 2004 Jul 16;279(29):30219-27. Epub 2004 May 17.

20.

Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.

Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F.

J Immunol. 2006 Aug 1;177(3):1855-63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk